Amid resounding evidence of increased disease severity and hopsitalisation among asthmatic and allergic patients among non-white populations, medical experts have highlighted the need for more inclusive recruitment in asthma, allergy studies. A recent clinical commentary review led by Christopher M. Warren, assistant professor of preventive medicine and director of population health research at the Center for Food Allergy & Asthma Research,  Northwestern University, found that there is an urgent need for improving the value of study results, particularly in respiratory diseases including COPD and asthma. The clinical commentary review, published in The Journal of Allergy and Clinical Immunology, underlined that the unequal representation of  Black, Asian, Middle Eastern, North African, Pacific Islander and Native American, as well as individuals of Hispanic or Latino ethnicity populations in these studies raises questions about the generalisability of results of many studies. The authors also wrote that clinical trial researchers also need to consider socioeconomic status, culture, geography, behavior and language, which are also often restricted to white populations in general.